drugset
drugset / Trial / NCT03996226

A Food-Effect Study of E7386 in Healthy Participants

NCT03996226 ↗

Phase 1 Completed 17 enrolled Eisai Inc.
RandomizedCrossoverOpen-labelOther

Summary

The primary objective of this study is to determine the effect of food in healthy participants on the bioavailability of E7386 following single dose administration with and without a meal.

Timeline

Start
2019-06-07
Primary completion
2019-10-29
Completion
2019-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject E7386 Small molecule — Oral

Indications

No indication recorded.